| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$1,019 |
Update - Notification of buy-back - IPH
|
15 Apr 2026 9:29AM |
$3.420 |
$3.975 |
risen by
16.23%
|
|
| XRF Scientific Limited (XRF) ORDINARY FULLY PAID |
Industrials |
$259 |
March 2026 Quarterly Trading Report
|
15 Apr 2026 9:28AM |
$1.810 |
$1.810 |
fallen by
0%
|
|
XRF - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for March 2026 quarter was $15.8 million, up 13.8% from previous year.
- Profit before tax for the quarter increased by 10.7% to $3.7 million.
- International sales were a key growth driver, particularly in Asia.
- New office in India became operational, boosting sales momentum.
- Capital equipment sales increased, with strong activity in the gold sector.
- Precious metals sales reached $5.6 million, up from $4.9 million previously.
- Focus on product development and international sales growth.
- Exploring merger and acquisition opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$47 |
Investor Presentation
|
15 Apr 2026 9:28AM |
$0.355 |
$0.250 |
fallen by
29.58%
|
|
| AuMEGA Metals Ltd (AAM) ORDINARY FULLY PAID |
Materials |
$49 |
AuMEGA Metals Closes C$30.1 Million Financing
|
15 Apr 2026 9:27AM |
$0.037 |
$0.034 |
fallen by
8.11%
|
|
AAM - Price-sensitive ASX Announcement
Full Release
Key Points
- AuMEGA Metals Ltd completed a C$30.1 million financing.
- Financing was done in two tranches according to ASX Listing Rules.
- First tranche raised approximately C$5.4 million.
- Second tranche raised approximately C$24.7 million after shareholder approval.
- The financing strengthens AuMEGA's balance sheet and supports large-scale exploration.
- Major institutional investors include Condire Investors, Nokomis Capital, Franklin Resources, and Schroders.
- The financing includes Hard Dollar Units, Premium Flow-Through Units, and Flow-Through Shares.
- Proceeds will fund exploration in Newfoundland, Canada, and support corporate purposes.
- AuMEGA plans expanded exploration programs in Cape Ray, Cape Ray West, and Bunker Hill.
- The financing enhances AuMEGA's institutional shareholder base.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$31 |
Noxopharm appoints Dr Olivier Laczka as new CEO
|
15 Apr 2026 9:27AM |
$0.058 |
$0.100 |
risen by
72.41%
|
|
NOX - Price-sensitive ASX Announcement
Full Release
Key Points
- Noxopharm appoints Dr Olivier Laczka as new CEO.
- Dr Laczka was the Chief Scientific Officer – Inflammation.
- Sofra™ platform focuses on autoimmune and inflammatory diseases.
- HERACLES clinical trial success boosts company growth potential.
- Chairman Fred Bart supports Dr Laczka's vision for growth.
- Dr Laczka aims to enhance shareholder value and seize opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$84 |
Immutep receives FDA ODD for Efti in Soft Tissue Sarcoma
|
15 Apr 2026 9:27AM |
$0.039 |
$0.057 |
risen by
46.15%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA granted Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma.
- ODD aims to encourage therapies for rare diseases with benefits like regulatory support and market exclusivity.
- EFTISARC-NEO trial showed significant results in tumor hyalinization with efti.
- Immutep develops immunotherapies targeting cancer and autoimmune diseases.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titanium Sands Limited (TSL) ORDINARY FULLY PAID |
Materials |
$19 |
Trading Halt
|
15 Apr 2026 9:26AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
TSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Titanium Sands Limited (ASX: TSL) requested a trading halt from the ASX.
- The trading halt is due to a pending announcement related to the Mannar Island Project and a funding facility.
- Trading halt to last until the announcement is made or by Friday, 17 April 2026.
- The company is not aware of any reasons why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,660 |
Acquires CAR Platform for Precision-Enhanced Cell Products
|
15 Apr 2026 9:25AM |
$2.010 |
$2.055 |
risen by
2.24%
|
|
| Firetrail Australian Small Companies Fund - Active ETF (FSML) |
Financials |
$509 |
March 2026 Investment Update
|
15 Apr 2026 9:24AM |
$2.130 |
$2.030 |
fallen by
4.69%
|
|
| GCQ Global Equities Hedged Complex ETF (HGCQ) GCQ GLOBAL EQUITIES HEDGED COMPLEX ETF |
Financials |
$19 |
Monthly Portfolio & Performance Update - March 2026
|
15 Apr 2026 9:24AM |
$4.990 |
$5.060 |
risen by
1.40%
|
|
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$25 |
Update - Notification of buy-back - CIW
|
15 Apr 2026 9:23AM |
$0.320 |
$0.298 |
fallen by
7.03%
|
|
| Clara Resources Australia Limited (C7A) ORDINARY FULLY PAID |
Materials |
$6 |
Cleansing Notice
|
15 Apr 2026 9:23AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$31 |
Change of & Final Directors Interest Notice (App 3Y & 3Z)-GM
|
15 Apr 2026 9:22AM |
$0.058 |
$0.100 |
risen by
72.41%
|
|
| Larvotto Resources Limited (LRV) ORDINARY FULLY PAID |
Materials |
$662 |
Hillgrove Development Advancing on Schedule
|
15 Apr 2026 9:22AM |
$1.175 |
$1.275 |
risen by
8.51%
|
|
LRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Hillgrove Antimony-Gold Project development is on time and within budget, with significant progress in Q1 2026.
- Federal government legislates Critical Minerals Stockpile with antimony as a key metal.
- David Fawcett appointed as advisor to progress CMS and refining opportunities.
- Processing plant refurbishment is on track for commissioning in August 2026.
- Underground development and rehabilitation activities are progressing well.
- Hillgrove is set to become Australia's largest antimony producer.
- Ongoing drilling success supports resource growth and potential mine life extension.
- Larvotto Resources Limited aims to be a major Western producer of antimony, gold, and tungsten.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riversgold Limited (RGL) ORDINARY FULLY PAID |
Materials |
$23 |
Impressive Kalgoorlie Gold Project Drilling Results Continue
|
15 Apr 2026 9:22AM |
$0.013 |
$0.010 |
fallen by
23.08%
|
|
RGL - Price-sensitive ASX Announcement
Full Release
Key Points
- 31 drillholes were completed at the Northern Zone Intrusive Hosted Gold Project
- Significant gold mineralisation intersected, with assays up to 71 g/t gold
- Project is part of Kalgoorlie Gold Project, located 25 km east of Kalgoorlie
- Mineralisation model validated, with expansion of mineralised footprint
- Project hosted within Tonalite-Trondhjemite Intrusion with high background gold
- Further drilling planned to define the limits of mineralisation
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WhiteHawk Limited (WHK) ORDINARY FULLY PAID |
Information Technology |
$5 |
Proposed issue of securities - WHK
|
15 Apr 2026 9:21AM |
$0.007 |
$0.004 |
fallen by
42.86%
|
|
| WhiteHawk Limited (WHK) ORDINARY FULLY PAID |
Information Technology |
$5 |
WhiteHawk Raises $1.5m at Premium
|
15 Apr 2026 9:21AM |
$0.007 |
$0.004 |
fallen by
42.86%
|
|
WHK - Price-sensitive ASX Announcement
Full Release
Key Points
- WhiteHawk Limited announces A$1.5 million share placement.
- Funds will be used for Quixxi Clarity AI integration and expansion.
- Placement of shares at $0.007 per share, a premium price.
- Acquisition enhances cybersecurity with AI governance capabilities.
- 214,285,714 new shares issued with attaching options.
- Shareholder approval required for certain components.
- Proceeds also cover working capital and placement costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qoria Limited (QOR) ORDINARY FULLY PAID |
Information Technology |
$344 |
Proposed issue of securities - QOR
|
15 Apr 2026 9:21AM |
$0.285 |
$0.250 |
fallen by
12.28%
|
|
| Magnum Mining and Exploration Limited (MGU) ORDINARY FULLY PAID |
Materials |
$16 |
NEW MANAGING DIRECTOR TO LEAD MAGNUM GROWTH
|
15 Apr 2026 9:20AM |
$0.007 |
$0.005 |
fallen by
23.08%
|
|
MGU - Price-sensitive ASX Announcement
Full Release
Key Points
- Mr Antonio Vitor Junior appointed as Managing Director.
- Major exploration campaigns at Azimuth REE and Parker Cu-Au Projects.
- Focus on delivering an Exploration Target and maiden JORC Mineral Resource.
- Strategic focus on Brazilian REE projects to realize shareholder value.
- Mr. Vitor Junior's significant experience in rare earth discovery and project leadership.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xenitra Limited (XEN) ORDINARY FULLY PAID |
Consumer Discretionary |
$13 |
Acquisition of Fukang OTC Pharmacy
|
15 Apr 2026 9:20AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
XEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of Hong Kong Fukang Trading Co., Limited by Xenitra Limited.
- Expansion of OTC medicine operations in Hong Kong and China.
- Inclusion of Hong Kong pharmaceutical wholesale license.
- Acquisition cost of ¥469,243.
- Strategic move to broaden product offerings in China.
- Endorsement by the board of directors.
- Integration of Fukang's existing team and assets into Xenitra.
- Alignment with Xenitra's market expansion goals in Asia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Rare Earths Limited (AR3) ORDINARY FULLY PAID |
Materials |
$27 |
Pilot plant preparations accelerating
|
15 Apr 2026 9:19AM |
$0.140 |
$0.105 |
fallen by
25%
|
|
| Great Northern Minerals Limited (GNM) ORDINARY FULLY PAID |
Materials |
$16 |
Acquisition of Advanced Gold-Silver Project in Nevada
|
15 Apr 2026 9:19AM |
$0.030 |
$0.032 |
risen by
6.67%
|
|
GNM - Price-sensitive ASX Announcement
Full Release
Key Points
- Great Northern Minerals Limited (GNM) announced the acquisition of an advanced gold-silver project in Nevada.
- The acquisition is part of GNM's strategic plans to expand its portfolio within the mineral-rich regions of the United States.
- The project site is noted for having significant historical drill results indicating high-grade gold-silver deposits.
- GNM sees this acquisition as a major step forward in diversifying their mining interests and increasing their exploration footprint in the United States.
- The acquisition aligns with GNM's vision of becoming a leading mineral exploration and development company.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firetrail Alpha Plus Fund - Complex ETF (FIRE) FIRETRAIL ALPHA PLUS FUND - COMPLEX ETF |
Financials |
$11 |
March 2026 Investment Update
|
15 Apr 2026 9:18AM |
$11.380 |
$11.260 |
fallen by
1.05%
|
|
| GCQ Global Equities Complex ETF (GCQF) |
Financials |
$263 |
Monthly Portfolio & Performance Update - March 2026
|
15 Apr 2026 9:16AM |
$4.020 |
$4.140 |
risen by
2.99%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$25 |
Update - Notification of buy-back - KME
|
15 Apr 2026 9:16AM |
$0.530 |
$0.480 |
fallen by
9.43%
|
|
Call 1300 880 160
Start a chat
Schedule a call
